Pacific biosciences of california stock.

You can hold this stock in a SIPP, ISA, JISA and Trading Account. Market Cap. $2.030bn. Div. Yield. -. Volume. 6,012,760. Open Price. $8.49. Prev. Close. $8.58.Stock Lists Headlines About Pacific Biosciences of California Stock Price, News & Analysis (NASDAQ:PACB) $8.55 +0.19 …Pacific Biosciences of California Stock Performance. Shares of NASDAQ PACB opened at $8.88 on Friday. The business has a fifty day simple moving average of $7.76 and a 200 day simple moving ...Pacific Biosciences of California, Inc. : News, information and stories for Pacific Biosciences of California, Inc. | Nasdaq: PACB | Nasdaq e5.obVqkYPOfJNKrd0Co_B5cEDheThrH58M33b_WYEND74.y-ES3Pr9L_cB-O5L7oYeOAiCA1UAWNt8kke9KdZaes-U4i_J76wr1xDpiAOverview News Pacific Biosciences of California Inc. No significant news for in the past two years. Shares Sold Short 35.12 M Change from Last -6.95% Percent of Float 13.74% …

PacBio Announces Third Quarter 2023 Financial Results. MENLO PARK, Calif. , Oct. 30, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2023 . Third quarter results Revenue of $55.7 million , a 72% increase compared with $32.3 million in the prior-year period. October 30, 2023.

PacBio Also Closes $300 Million PIPE Financing in Support of Transaction. MENLO PARK, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, long-read sequencing platforms, and Omniome, a San Diego-based …Nov 29, 2023

Discover historical prices for PACB stock on Yahoo Finance. View daily, weekly or monthly format back to when Pacific Biosciences of California, Inc. stock was issued. Home. Mail; News; Sports; ... Pacific Biosciences of California, Inc. (PACB) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Add to watchlist. 6.52 0.00 (0.00%)Aug 2, 2023 · Pacific Biosciences (PACB) delivered earnings and revenue surprises of 23.53% and 17.95%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? Pacific Biosciences Of California reported $68.26M in Stock for its fiscal quarter ending in September of 2023. Data for Pacific Biosciences Of California ...Pacific Biosciences of California Inc (NASDAQ: PACB) has seen a rise in its stock price by 10.74 in relation to its previous close of 6.52. However, the company has experienced a 1.55% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2023-10-31 that PacBio (PACB) witnesses strong revenue …Pacific Biosciences. Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. [2] [3] [failed verification] PacBio has two principal sequencing platforms: single-molecule real-time ...

Asia Pacific; CORPORATE INQUIRIES ... California 6965 Lusk Boulevard San Diego, CA 92121 USA ... United Kingdom Rolling Stock Yard 188 York Way London, N7 9AS UK ...

Pacific Biosciences of California, Inc. (PACB) NASDAQ: PACB · IEX Real-Time Price · USD. Add to Watchlist 8.55 +0.19 (2.27%) At close: Nov 24, 2023, 1:00 PM. 8.75 ... According to 10 stock analysts, the average 12-month stock price forecast for PACB stock stock is $11.8, which predicts an increase of 38.01%. The lowest target is …

The firm now holds 59,626 shares of the biotechnology company’s stock, after selling 59,343 shares in the quarter. According to financial data as of the end of the reporting period, these holdings were valued at $793,000. Pacific Biosciences of California is a renowned biotechnology company that specializes in genetic sequencing …Pacific Biosciences of California Stock Forecast and Price Target. Year-long price target forecasts from four prominent analysts have recently been released for Pacific Biosciences of California, with an average price target of $10.50. This potential gain of 24.41 percent from the previous closing price in November, 2023 is calculated on …Nov 26, 2023 · Pacific Biosciences of California Stock Up 2.3 %. Shares of NASDAQ:PACB opened at $8.55 on Friday. The company has a debt-to-equity ratio of 1.17, a current ratio of 4.80 and a quick ratio of 4.43. Pacific Biosciences of California (NASDAQ:PACB) and Olink Holding AB (publ) are both mid-cap medical companies, but which is the superior business?We will compare the two businesses based on the strength of their profitability, institutional ownership, community ranking, earnings, media sentiment, analyst recommendations, …١٦‏/٠٨‏/٢٠٢٣ ... Why Pacific Biosciences of California Inc's (PACB) Stock Is Down 4.55% ... One of the most dreaded feelings for an investor is when the stock they ...

Pacific Biosciences of California, Inc. Common Stock (PACB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Pacific Biosciences of California Inc. published this content on 15 November 2022 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 15 November 2022 20:01:02 UTC .Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) gapped up prior to trading on Friday .The stock had previously closed at $6.52, but opened at $6.92. Pacific Biosciences ...MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2021.Pacific Biosciences of California Inc Stock , PACB 8.95 +0.07 +0.79% After-market 07:47:07 PM EDT 12/1/2023 NASShares of Pacific Biosciences of California Inc. tumbled 3% in morning trading the day after the Federal Trade Commission announced plans to challenge Illumina Inc.'s plans …The Pacific Biosciences of California stock prediction results are shown below and presented as a graph, table and text information. Pacific Biosciences of California stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Pacific Biosciences of California analysts is $. Today ...

Over the last year, Pacific Biosciences of California, Inc.’s stock price has decreased by 17.39%. Pacific Biosciences of California, Inc. is currently approximately $8.55 per share.Pacific Biosciences of California Inc’s Stock Price as of Market Close As of November 14, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $7.22. Pacific Biosciences of California Inc is up 12.11% from its previous closing price of $6.44.

As of November 17, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $8.40. Pacific Biosciences of California Inc is up 10.67% from its previous closing price of $7.59. During the last market session, Pacific Biosciences of California Inc’s stock traded between $7.44 and $7.68.As of November 17, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $8.40. Pacific Biosciences of California Inc is up 10.67% from its previous closing price of $7.59. During the last market session, Pacific Biosciences of California Inc’s stock traded between $7.44 and $7.68.Pacific Biosciences of California last issued its quarterly earnings results on October 30th, 2023. The biotechnology company reported ($0.27) earnings per share for the quarter, beating analysts' consensus estimates of ($0.29) by $0.02. The business earned $55.70 million during the quarter, compared to analyst estimates of $48.76 million.Pacific Biosciences of California Stock Forecast 11-26-2023. Forecast target price for 11-26-2023: $ 8.02. Negative dynamics for Pacific Biosciences of California shares will prevail with possible volatility of 5.469%. Pessimistic target level: 7.80.Pacific Biosciences of California Inc’s price is currently down 3.85% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $10.00 and a low of $8.01. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85.24 Jan, 2023, 23:18 ET. MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously ...SAN DIEGO & MENLO PARK, Calif.--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that they have mutually agreed to terminate their merger agreement, previously announced on November 1, 2018, under which Illumina would acquire Pacific Biosciences at a fully diluted enterprise value of approximately $1.2 billion in an all ...US Stock MarketDetailed Quotes. PACB Pacific Biosciences of California. Close 11/13 16:00 ET. 6.440. -0.080 -1.23%. High 6.525. Low 6.175. Volume4.80M. Post ...

Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report)’s stock price dropped 4% on Monday .The company traded as low as $8.14 and last traded at $8.21. Approximately 282,223 ...

Overview News Pacific Biosciences of California Inc. No significant news for in the past two years. Shares Sold Short 35.12 M Change from Last -6.95% Percent of Float 13.74% …

Interactive Chart for Pacific Biosciences of California, Inc. (PACB), analyze all the data with a huge range of indicators.Pacific Biosciences of California Inc (NASDAQ: PACB) has experienced a rise in its stock price by 4.67 compared to its previous closing price of 8.36. However, the company has seen a gain of 15.28% in its stock price over the last five trading days. Seeking Alpha reported 2023-11-20 that Pacific Biosciences reported a 72% YoY […]MENLO PARK, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced the appointment of Susan G. Kim as Chief Financial Officer, effective as of September 28, …Pacific Biosciences of California last issued its quarterly earnings results on October 30th, 2023. The biotechnology company reported ($0.27) earnings per share for the quarter, beating analysts' consensus estimates of ($0.29) by $0.02. The business earned $55.70 million during the quarter, compared to analyst estimates of $48.76 million.Get Pacific Biosciences of California Inc (PACB.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments ... Stocks. Index Last % Change ...Pacific Biosciences of California has been profitable 1 over the past 10 years. Over the past twelve months, the company had a revenue of $146.10 million and Loss Per Share of $1.35.On average, Wall Street analysts predict. that Pacific Biosciences Of California's share price could reach $10.57 by Nov 17, 2024. The average Pacific Biosciences Of California stock price prediction forecasts a potential upside of …See the latest Pacific Biosciences of California Inc stock price (PACB:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Pacific Biosciences of California Inc (NASDAQ: PACB) has seen a rise in its stock price by 10.74 in relation to its previous close of 6.52. However, the company has experienced a 1.55% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2023-10-31 that PacBio (PACB) witnesses strong revenue …A steep rise in short interest was recorded in Pacific Biosciences of California Inc stocks on Oct 30, 2023, growing by 2.05 million shares to a total of 35.12 million shares. Yahoo Finance data shows the prior-month short interest on Sep 28, 2023 was 33.07 million shares. There was a rise of 5.84%, which implies that there is a …Get the latest Pacific Biosciences of California Inc. (PACB) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.Pacific Biosciences of California, Inc. (PACB) latest earnings report: revenue, EPS, surprise, history, news and analysis.

Source: Shutterstock. We wouldn't blame Pacific Biosciences of California, Inc. NASDAQ:PACB) shareholders if they were a little worried about the fact that Christian O. Henry, the President recently netted about US$980k selling shares at an average price of US$10.12. That sale reduced their total holding by 29% which is hardly …Pacific Biosciences of California Stock Up 4.7 %. Pacific Biosciences of California stock opened at $8.88 on Friday. The company has a debt-to-equity ratio of 1.17, a quick ratio of 4.43 and a ...Nov 27, 2023 · Pacific Biosciences of California Non-GAAP EPS of -$0.35 beats by $0.02, revenue of $27.35M beats by $0.06M SA News Thu, Feb. 16 Pacific Biosciences of California Q4 2022 Earnings Preview Pacific Biosciences (PACB) Has Made a Bottom Pattern: Prices to Watch...PACB Pacific Biosciences of California Inc. (PACB) is a biotechnology company that develops and manufactures systems for gene sequencing and biological observation. Let...Instagram:https://instagram. lemonade term lifefranklin income fundswysh life insurance reviewslincoln national corporation stock The notes will have a conversion price of $43.50 per share of the company's common stock, representing a 10% premium over Pacific Biosciences' share price as of the end of yesterday's trading session. toronto dominion share pricemcary MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2021. bed bath and beyond stocktwits Real time Pacific Biosciences Of California (PACB) stock price quote, stock graph, news & analysis.Pacific Biosciences of California, Inc. : News, information and stories for Pacific Biosciences of California, Inc. | Nasdaq: PACB | Nasdaq e5.obVqkYPOfJNKrd0Co_B5cEDheThrH58M33b_WYEND74.y-ES3Pr9L_cB-O5L7oYeOAiCA1UAWNt8kke9KdZaes-U4i_J76wr1xDpiA